RB Global CapEx decreased by 25.0% to $51.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.2%, from $54.30M to $51.50M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 126.7% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.06M | $2.37M | $2.82M | $2.00M | $2.50M | $21.80M | $5.70M | $23.50M | $68.70M | $61.40M | $74.30M | $45.20M | $28.70M | $36.90M | $56.60M | $54.30M | $84.80M | $51.20M | $68.70M | $51.50M |
| QoQ Change | — | -22.6% | +18.9% | -29.0% | +25.0% | +772.0% | -73.9% | +312.3% | +192.3% | -10.6% | +21.0% | -39.2% | -36.5% | +28.6% | +53.4% | -4.1% | +56.2% | -39.6% | +34.2% | -25.0% |
| YoY Change | — | — | — | — | -18.3% | +820.6% | +102.4% | >999% | >999% | +181.7% | >999% | +92.3% | -58.2% | -39.9% | -23.8% | +20.1% | +195.5% | +38.8% | +21.4% | -5.2% |